Jefferies Financial Group Inc. Has $5.75 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Jefferies Financial Group Inc. increased its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 98.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 83,100 shares of the company's stock after acquiring an additional 41,300 shares during the period. Jefferies Financial Group Inc. owned approximately 0.07% of Henry Schein worth $5,751,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Venturi Wealth Management LLC boosted its holdings in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after acquiring an additional 569 shares in the last quarter. Quent Capital LLC lifted its stake in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares in the last quarter. City State Bank bought a new stake in Henry Schein during the fourth quarter worth approximately $55,000. Finally, Allworth Financial LP grew its position in Henry Schein by 180.7% in the fourth quarter. Allworth Financial LP now owns 946 shares of the company's stock worth $71,000 after buying an additional 609 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the stock. StockNews.com lowered shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research report on Thursday, January 23rd. Piper Sandler decreased their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 30th. Wells Fargo & Company decreased their price target on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Finally, UBS Group decreased their price target on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $79.30.

Henry Schein Trading Up 0.7%

Shares of NASDAQ:HSIC traded up $0.51 during mid-day trading on Friday, hitting $72.05. The stock had a trading volume of 1,036,158 shares, compared to its average volume of 1,645,302. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market cap of $8.77 billion, a PE ratio of 29.65, a P/E/G ratio of 2.13 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company's 50 day moving average is $67.34 and its 200-day moving average is $71.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the prior year, the firm earned $1.10 EPS. The firm's quarterly revenue was down .1% on a year-over-year basis. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.